{"messages":[{"status":"ok","category":"all","interval":"2020-01-01:2020-01-31","funder":"all","cursor":0,"count":30,"count_new_papers":"224","total":"266"}], "collection":[{"title":"How comprehensive is the Cochrane Central Register of Controlled Trials for identifying clinical trial registration?: the protocol of a diagnostic study","authors":"Banno, M.; Tsujimoto, Y.; Kataoka, Y.","author_corresponding":"Masahiro Banno","author_corresponding_institution":"Department of Psychiatry, Seichiryo Hospital","doi":"10.1101\/2019.12.26.19014274","date":"2020-01-02","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nd","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/01\/02\/2019.12.26.19014274.source.xml","abstract":"ObjectivesTo evaluate whether or not systematic reviewers can use Cochrane Central Register of Controlled Trials (CENTRAL) to identify ongoing and unpublished studies instead of searching International Clinical Trials Registry Platform (ICTRP) and ClinicalTrials.gov (CT.gov).\n\nMethodsThis will be a diagnostic accuracy test study. We will collect a consecutive sample of ongoing or unpublished studies on Cochrane Database of Systematic Reviews (CDSRs) during the last six months. We will use all of the records as our reference standard and evaluated whether they are part of the CENTRAL search presented in the CDSRs.\n\nThe index test is the CENTRAL search using the search terms in the CDSRs, and the reference standard is the list of ongoing or unpublished studies registered on the ICTRP or CT.gov in the CDSRs.\n\nWe will assess the sensitivity and number needed to read.\n\nEthics & DisseminationThis study does not require ethics approval. We registered this study protocol. We will publish the findings in a peer-reviewed journal and may present them at conferences.\n\nDiscussionThis study may lessen the burden of systematic reviewers if this study clarifies CENTRAL search can be used for screening in records about ongoing or unpublished studies.\n\nRegistrationUMIN-CTR: UMIN000038981\n\nAuthor name abbreviationsMasahiro Banno (MB), Yasushi Tsujimoto (YT), Yuki Kataoka (YK)","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Germline mutation rates in young adults predict longevity and reproductive lifespan","authors":"Cawthon, R. M.; Meeks, H. D.; Sasani, T. A.; Smith, K. R.; Kerber, R. A.; O'Brien, E.; Baird, L.; Dixon, M. M.; Peiffer, A. P.; Leppert, M. F.; Quinlan, A. R.; Jorde, L. B.","author_corresponding":"Richard M Cawthon","author_corresponding_institution":"University of Utah, Dept. of Human Genetics","doi":"10.1101\/19004184","date":"2020-01-02","version":"3","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/01\/02\/19004184.source.xml","abstract":"BACKGROUNDAnalysis of sequenced genomes from large three-generation families allows de novo mutations identified in Generation II individuals to be attributed to each of their parents germlines in Generation I. Because germline mutations increase with age, we hypothesized that they directly limit the duration of childbearing in women, and if correlated with mutation accumulation in somatic tissues, also reflect systemic aging in both sexes. Here we test whether the germline mutation rates of Generation I individuals when they were young adults predict their remaining survival, as well as the womens reproductive lifespans.\n\nMETHODSGermline autosomal mutation counts in 122 Generation I individuals (61 women, 61 men) from 41 three-generation Utah CEPH families were converted to germline mutation rates by normalizing each subjects number of mutations to the callable portion of their genome. Age at death, cause of death, all-site cancer incidence, and reproductive histories were provided by the Utah Population Database, Cancer Registry, and Utah Genetic Reference Project. Fertility analyses were restricted to the 53 women whose age at last birth (ALB) was at least 30 years, the approximate age when the decline in female fertility begins. Cox proportional hazard regression models were used to test the association of age-adjusted mutation rates (AAMRs) with aging-related outcomes. Linear regression analysis was used to estimate the age when adult germline mutation accumulation rates are established.\n\nFINDINGSQuartiles of increasing AAMRs were associated with increasing all-cause mortality rates in both sexes combined (test for trend, p=0.009); subjects in the top quartile of AAMRs experienced more than twice the mortality of bottom quartile subjects (hazard ratio [HR], 2.07; 95% confidence interval [CI], 1.21-3.56; p=0.008; median survival difference = 4.7 years). Women with higher AAMRs had significantly fewer live births and a younger ALB. The analyses also indicate that adult germline mutation accumulation rates are established in adolescence, and that later menarche in women may delay mutation accumulation.\n\nINTERPRETATIONParental-age-adjusted germline mutation rates in healthy young adults may provide a measure of both reproductive and systemic aging. Puberty may induce the establishment of adult mutation accumulation rates, just when DNA repair genes expression levels are known to begin their lifelong decline.\n\nFUNDINGNIH R01AG038797 and R21AG054962 (to R.M.C.); University of Utah Program in Personalized Health (to H.D.M.); NIH T32GM007464 (to T.A.S.); NIH R01AG022095 (to K.R.S.); NIH R01HG006693, R01HG009141, and R01GM124355 (to A.R.Q.); NIH GM118335 and GM059290 (to L.B.J.); NIH P30CA2014 (to the Utah Population Database, a.k.a. the UPDB); National Center for Research Resources Public Health Services grant M01RR00064 (to the Huntsman General Clinical Research Center, University of Utah); National Center for Advancing Translational Sciences NIH grant UL1TR002538 (to the University of Utahs Center for Clinical and Translational Science); Howard Hughes Medical Institute funding (to Ray White); gifts from the W.M. Keck Foundation (to Stephen M. Prescott and M.F.L.) and from the George S. and Delores Dore Eccles Foundation (to the University of Utah) that supported the Utah Genetic Reference Project (UGRP). Sequencing of the CEPH samples was funded by the Utah Genome Project, the George S. and Dolores Dore Eccles Foundation, and the H.A. and Edna Benning Foundation. We thank the Pedigree and Population Resource of the Huntsman Cancer Institute, University of Utah (funded in part by the Huntsman Cancer Foundation) for its role in the ongoing collection, maintenance and support of the UPDB.","funder":"NA","published":"10.1038\/s41598-020-66867-0","server":"medRxiv"},{"title":"Precision Multiparameter Tracking of Inflammation on Timescales of Hours to Years Using Serial Dried Blood Spots","authors":"Anderson, N. L.; Razavi, M.; Pope, M.; Yip, R.; Cameron, L. C.; Basini-Cameron, A.; Pearson, T. W.","author_corresponding":"Norman Leigh Anderson","author_corresponding_institution":"SISCAPA Assay Technologies, Inc.","doi":"10.1101\/2019.12.09.19014233","date":"2020-01-02","version":"2","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"pharmacology and therapeutics","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/01\/02\/2019.12.09.19014233.source.xml","abstract":"High-frequency longitudinal tracking of inflammation using dried blood microsamples provides a new window for personalized monitoring of infections, chronic inflammatory disease, and clinical trials of anti-inflammatory drugs. Using 1,662 dried blood spot samples collected by 16 subjects over periods of weeks to years, we studied the behavior of 12 acute phase response (APR) and related proteins in inflammation events correlated with infection, vaccination, surgery, intense exercise and Crohns disease. Proteins were measured using SISCAPA mass spectrometry and normalized to constant plasma volume using low-variance proteins, generating high precision within-person biomarker trajectories with well-characterized personal baselines. The results shed new light on the dynamic regulation of APR proteins and offer a new approach to visualization of multidimensional inflammation trajectories.","funder":"NA","published":"10.4155\/bio-2019-0278","server":"medRxiv"},{"title":"Everolimus improves the efficacy of dasatinib in the treatment of PDGFRA-driven glioma","authors":"Miklja, Z.; Yadav, V. N.; Cartaxo, R.; Siada, R.; Mullan, B.; Stallard, S.; Paul, A.; Bruzek, A. K.; Wierzbicki, K.; Yang, T.; Garcia, T.; Wolfe, I.; Parmar, H.; Leonard, M.; Robertson, P. L.; Garton, H.; Venneti, S.; Kumar-Sinha, C.; Chinnaiyan, A.; Mody, R.; Manjunath, P. P.; Phoenix, T. N.; Marini, B. L.; Koschmann, C.","author_corresponding":"Carl Koschmann","author_corresponding_institution":"University of Michigan","doi":"10.1101\/2019.12.28.19015974","date":"2020-01-02","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"oncology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/01\/02\/2019.12.28.19015974.source.xml","abstract":"BackgroundPediatric and adult high-grade glioma (HGG) frequently harbor PDGFRA alterations. We hypothesized that co-treatment with everolimus may improve the efficacy of dasatinib in PDGFR-driven glioma through combinatorial synergism and increased tumor accumulation of dasatinib.\n\nMethodsDose response, synergism studies, P-gp inhibition and pharmacokinetic studies were performed on in vitro and in vivo human and mouse models of HGG. Six patients with recurrent PDGFR-driven glioma were treated with dasatinib and everolimus.\n\nResultsDasatinib effectively inhibited the proliferation of mouse and human primary HGG cells with a variety of PDGFRA alterations. Dasatinib exhibited synergy with everolimus in the treatment of HGG cells at low nanomolar concentrations of both agents, with reduction in mTOR signaling that persists after dasatinib treatment alone. Prolonged exposure to everolimus significantly improved the CNS retention of dasatinib and extended survival of PPK tumor bearing mice. Pediatric patients (n=6) with glioma tolerated this combination without significant adverse events. Recurrent patients (n=4) demonstrated median overall survival of 8.5 months.\n\nConclusionEfficacy of dasatinib treatment of PDGFR-driven HGG is improved with everolimus and suggests a promising route for improving targeted therapy for this patient population.\n\nTrial RegistrationClinicalTrials.gov NCT03352427\n\nFundingThe authors thank the patients and their families for participation in this study. CK is supported by NIH\/NINDS K08-NS099427-01, the University of Michigan Chad Carr Pediatric Brain Tumor Center, the Chad Tough Foundation, Hyundai Hope on Wheels, Catching up With Jack, Prayers from Maria Foundation, U CAN-CER VIVE FOUNDATION, Morgan Behen Golf Classic, and the DIPG Collaborative. The PEDS-MIONCOSEQ study was supported by grant 1UM1HG006508 from the National Institutes of Health Clinical Sequencing Exploratory Research Award (PI: Arul Chinnaiyan).","funder":"NA","published":"10.1172\/JCI133310","server":"medRxiv"},{"title":"Temporal Relationship of Computed and Structured Diagnoses in Electronic Health Record Data","authors":"Schulz, W. L.; Young, H. P.; Coppi, A.; Mortazavi, B. J.; Lin, Z.; Jean, R. A.; Krumholz, H. M.","author_corresponding":"Harlan M Krumholz","author_corresponding_institution":"Yale School of Medicine","doi":"10.1101\/2019.12.28.19015628","date":"2020-01-02","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"health informatics","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/01\/02\/2019.12.28.19015628.source.xml","abstract":"The electronic health record (EHR) holds the prospect of providing more complete and timely access to clinical information for studies, quality assessments, and quality improvement compared to other data sources, such as administrative claims. Our goal was to assess the completeness and timeliness of structured diagnoses in the EHR compared to computed diagnoses for hypertension (HTN), hyperlipidemia (HLD), and diabetes mellitus (DM). We determined the amount of time for a structured diagnosis to be recorded in the EHR from when an equivalent diagnosis could be computed from other structured data elements, such as vital signs and laboratory results. Using our local instance of EHR data in the PCORnet common data model (CDM) with encounters from January 1, 2012 through February 10, 2019, we identified patients with at least two observations above threshold separated by at least 30 days. The thresholds were outpatient blood pressure of [&ge;] 140\/90 mmHg, any low-density lipoprotein [&ge;] 130 mg\/dl, or any hemoglobin A1c [&ge;] 7%, respectively. The primary measure was the length of time between the computed diagnosis and the time at which a structured diagnosis could be identified within the EHR history or problem list. We found that 39.8% of those with HTN, 21.6% with HLD, and 1.0% with DM did not receive a corresponding structured diagnosis recorded in the EHR. For those who received a structured diagnosis, a mean of 389, 198, and 106 days elapsed before the patient had the corresponding diagnosis of HTN, HLD, or DM, respectively, recorded in the EHR. We identified a marked temporal delay between when a diagnosis can be computed or inferred and when an equivalent structured diagnosis is recorded within the EHR. These findings demonstrate the continued need for additional study of the EHR to avoid bias when using observational data and reinforce the need for computational approaches to identify clinical phenotypes.","funder":"NA","published":"10.1186\/s12911-021-01416-x","server":"medRxiv"},{"title":"Longitudinal characterization of Plasmodium inter-species interactions during a period of 1 increasing prevalence of Plasmodium ovale","authors":"Akala, H. M.; Watson, O.; Mitei, K. K.; Juma, D. W.; Verity, R.; Ingasia, L. A.; Opot, B. H.; Okoth, R. O.; Chemwor, G. C.; Juma, J. A.; Mwakio, E. W.; Brazeau, N.; Cheruiyot, A. C.; Yeda, R. A.; Maraka, M. N.; Okello, C. O.; Andagalu, B.; Ogutu, B. R. R.; Managbanag, J. R.; Kamau, E.; Kateete, D. P.","author_corresponding":"Hoseah Miima Akala","author_corresponding_institution":"US Army Medical Research Directorate-Africa and The KEnya Medical Research Institute","doi":"10.1101\/2019.12.28.19015941","date":"2020-01-02","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"infectious diseases","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/01\/02\/2019.12.28.19015941.source.xml","abstract":"BackgroundThe epidemiology and severity of non-falciparum malaria in endemic settings has garnered limited attention. We aimed to characterize the prevalence, interaction, clinical risk factors and temporal trends of non-falciparum malaria in endemic settings of Kenya.\n\nMethodsWe diagnosed and analyzed infecting malaria species via PCR in 2027 clinical samples collected between 2008 and 2016. Descriptive statistics were used to describe the prevalence and distribution of Plasmodium species. A statistical model was designed and used for estimating the frequency of Plasmodium species and assessing inter-species interactions. Mixed effect linear regression models with random intercepts for each location was used to test for change in prevalence over time.\n\nFindings72*5% of the samples were P. falciparum single species infections, 25{middle dot}8% were mixed infections and only 1*7% occurred as single non-falciparum species infections. 23*1% were mixed infections containing P. ovale. A likelihood-based model calculation of the population frequency of each species estimated a significant within-host interference between P. falciparum and P. ovale curtisi. Mixed-effect logistic regression models identified a significant increase of P. ovale wallikeri and P. ovale curtisi species over time with reciprocal decrease in P. falciparum single species and P. malariae. The risk of P. falciparum infections presenting with fever was 0*43 times less likely if co-infected with P. malariae.\n\nInterpretationFindings show higher prevalence of non-falciparum malaria than expected. The proportion of infections that were positive for infection by P. ovale wallikeri and P. ovale curtisi was observed to significantly increase over the period of study which could be due to attenuated responsiveness to malaria drug treatment on these species. The increase in frequency of P. ovale spp in Kenya could threaten malaria control effort in Kenya and pose increased risk of malaria to travelers.\n\nFundingAFHSB and its GEIS Section","funder":"NA","published":"10.1016\/s2666-5247(21)00009-4","server":"medRxiv"},{"title":"A Preoperative Estimate of Central Venous Pressure Is Associated with Early Fontan Failure","authors":"Quail, M. A.; Chan, I.; Sarna, S.; Hughes, M.; Muthurangu, V.","author_corresponding":"Michael A Quail","author_corresponding_institution":"UCL","doi":"10.1101\/2019.12.28.19016048","date":"2020-01-02","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"cardiovascular medicine","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/01\/02\/2019.12.28.19016048.source.xml","abstract":"ObjectiveEarly Fontan Failure (EFF) is a serious complication following total cavopulmonary connection (TCPC), characterised by high central venous pressure (CVP), low cardiac output and resistance to medical therapy. This study aimed to estimate post-operative CVP in TCPC patients (CVPTCPC) using data routinely collected during pre-operative assessment. We sought to determine if this metric correlated with measured post-operative CVP and if it was associated with EFF.\n\nMethodsIn this retrospective study, CVPTCPC was estimated in 131 patients undergoing pre-TCPC assessment by cardiac magnetic resonance imaging and CVP measurement under general anaesthesia. Post-operative CVP during the first 24hours in ICU was collected from electronic patient records in a subset of patients. EFF was defined as death, transplantation, TCPC takedown or emergency fenestration within the first 30days.\n\nResultsEstimated CVPTCPC correlated significantly with CVPICU (r=0.26, p=0.03), particularly in patients without a fenestration (r=0.45, p=0.01). CVPTCPC was significantly associated with EFF (Odds Ratio [OR] 1.12 (1.02-1.24), p=0.02). A threshold of CVPTCPC [&ge;]33mmHg was found to have the highest specificity (90%) and sensitivity (67%) for identifying EFF (area under receiver operating curve, AUC = 0.79), OR 18.8 (3.1-114), p=0.001. This association was stronger in patients with single SVCs.\n\nConclusionsEstimated CVPTCPC is an easily calculated metric combining pre-operative pressure and flow data. Higher CVPTCPC is associated with an increased risk of EFF and is correlated with directly measured post-TCPC pressure. Identification of patients at risk of EFF has the potential to guide risk mitigation strategies.","funder":"NA","published":"10.1016\/j.jtcvs.2020.06.025","server":"medRxiv"},{"title":"Evaluating the performance of the WHO international reference standard for osteoporosis diagnosis in postmenopausal women of varied polygenic score and race","authors":"Wu, Q.; Xiao, X.; Xu, Y.","author_corresponding":"Qing Wu","author_corresponding_institution":"UNIVERSITY OF NEVADA LAS VEGAS","doi":"10.1101\/2019.12.30.19016154","date":"2020-01-02","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/01\/02\/2019.12.30.19016154.source.xml","abstract":"BackgroundWhether the bone mineral density (BMD) T-score performs differently in osteoporosis classification in women of different genetic profiling and race background remains unclear.\n\nMethodsThe genomic data in the Womens Health Initiative study was analyzed (n=2,417). The polygenic score (PGS) was calculated from 63 BMD-associated single nucleotide polymorphisms (SNPs) for each participant. The World Health Organizations (WHO) definition of osteoporosis (BMD T-score[&le;]-2.5) was used to estimate the cumulative incidence of fracture.\n\nResultsT-score classification significantly underestimated the risk of major osteoporotic fracture (MOF) in the WHI study. An enormous underestimation was observed in African American women (POR: 0.52, 95% CI: 0.30-0.83) and in women with low PGS (predicted\/observed ratio [POR]: 0.43, 95% CI: 0.28-0.64). Compared to Caucasian women, African American, African Indian, and Hispanic women respectively had a 59%, 41%, and 55% lower hazard of MOF after the T-score was adjusted for. The results were similar when used for any fractures.\n\nConclusionsOur study suggested the BMD T-score performance varies significantly by race in postmenopausal women.","funder":"NA","published":"10.3390\/jcm9020499","server":"medRxiv"},{"title":"Taxonomic Signatures of Long-Term Mortality Risk in Human Gut Microbiota","authors":"Salosensaari, A.; Laitinen, V.; Havulinna, A. S.; Meric, G.; Cheng, S.; Perola, M.; Valsta, L.; Alfthan, G.; Inouye, M.; Watrous, J. D.; Long, T.; Salido, R.; Sanders, K.; Brennan, C.; Humphrey, G. C.; Sanders, J. G.; Jain, M.; Jousilahti, P.; Salomaa, V.; Knight, R.; Lahti, L.; Niiranen, T.","author_corresponding":"Teemu Niiranen","author_corresponding_institution":"Division of Medicine, Turku University Hospital and University of Turku, Turku, Finland; National Institute for Health and Welfare, Helsinki, Finland","doi":"10.1101\/2019.12.30.19015842","date":"2020-01-02","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/01\/02\/2019.12.30.19015842.source.xml","abstract":"The collection of fecal material and developments in sequencing technologies have enabled cost-efficient, standardized, and non-invasive gut microbiome profiling. As a result, microbiome composition data from several large cohorts have been cross-sectionally linked to various lifestyle factors and diseases.1-5 In spite of these advances, prospective associations between microbiome composition and health have remained uncharacterized due to the lack of sufficiently large and representative population cohorts with comprehensive follow-up data.6-8 Here, we analyse the long-term association between gut microbiome variation and mortality in a large, well-phenotyped, and representative population cohort (n = 7211, FINRISK 2002; Finland).9 We report specific taxonomic and functional signatures related to the Enterobacteriaceae family in the human gut microbiome that predict mortality during a 15-year follow-up. These associations can be observed both in the Eastern and Western Finns who have differing genetic backgrounds, lifestyles, and mortality rates.10,11 Our results supplement previously reported cross-sectional associations,1-4,12 and help to establish a methodological and conceptual basis for examining long-term associations between human gut microbiome composition, incident outcomes, and general health status. These findings could serve as a solid framework for microbiome profiling in clinical risk prediction, paving the way towards clinical applications of human microbiome sequencing aimed at prediction, prevention, and treatment of disease.","funder":"NA","published":"10.1038\/s41467-021-22962-y","server":"medRxiv"},{"title":"Classification of glomerular pathological findings using deep learning and nephrologist-AI collective intelligence approach","authors":"Uchino, E.; Suzuki, K.; Sato, N.; Kojima, R.; Tamada, Y.; Hiragi, S.; Yokoi, H.; Yugami, N.; Minamiguchi, S.; Haga, H.; Yanagita, M.; Okuno, Y.","author_corresponding":"Yasushi Okuno","author_corresponding_institution":"Department of Biomedical Data Intelligence, Graduate School of Medicine, Kyoto University, Kyoto, Japan","doi":"10.1101\/2019.12.30.19016162","date":"2020-01-02","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"pathology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/01\/02\/2019.12.30.19016162.source.xml","abstract":"BackgroundAutomated classification of glomerular pathological findings is potentially beneficial in establishing an efficient and objective diagnosis in renal pathology. While previous studies have verified the artificial intelligence (AI) models for the classification of global sclerosis and glomerular cell proliferation, there are several other glomerular pathological findings required for diagnosis, and the comprehensive models for the classification of these major findings have not yet been reported. Whether the cooperation between these AI models and clinicians improves diagnostic performance also remains unknown. Here, we developed AI models to classify glomerular images for major findings required for pathological diagnosis and investigated whether those models could improve the diagnostic performance of nephrologists.\n\nMethodsWe used a dataset of 283 kidney biopsy cases comprising 15888 glomerular images that were annotated by a total of 25 nephrologists. AI models to classify seven pathological findings: global sclerosis, segmental sclerosis, endocapillary proliferation, mesangial matrix accumulation, mesangial cell proliferation, crescent, and basement membrane structural changes, were constructed using deep learning by fine-tuning of InceptionV3 convolutional neural network. Subsequently, we compared the agreement to truth labels between majority decision among nephrologists with or without the AI model as a voter.\n\nResultsOur model for global sclerosis showed high performance (area under the curve: periodic acid-Schiff, 0.986; periodic acid methenamine silver, 0.983); the models for the other findings also showed performance close to those of nephrologists. By adding the AI model output to majority decision among nephrologists, the sensitivity and specificity were significantly improved in 9 of 14 constructed models compared to those of nephrologists alone.\n\nConclusionOur study showed a proof-of-concept for the classification of multiple glomerular findings in a comprehensive method of deep learning and suggested its potential effectiveness in improving diagnostic accuracy of clinicians.","funder":"NA","published":"10.1016\/j.ijmedinf.2020.104231","server":"medRxiv"},{"title":"How to implement and use findings from patient experience surveys in Australian general practice: A qualitative expert consultation study","authors":"Song, H. J.; Dennis, S.; Levesque, J.-F.; Harris, M.","author_corresponding":"Hyun Jung Song","author_corresponding_institution":"University of New South Wales","doi":"10.1101\/2019.12.30.19016121","date":"2020-01-02","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"primary care research","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/01\/02\/2019.12.30.19016121.source.xml","abstract":"An earlier version of this manuscript was removed owing to confidential information relating to an individual","funder":"NA","published":"10.1136\/ihj-2019-000033","server":"medRxiv"},{"title":"Early screening of autism spectrum disorder using cry features","authors":"Khozaei, A.; Moradi, H.; Hosseini, R.; Pouretemad, H.; Eskandari, B.","author_corresponding":"Hadi Moradi","author_corresponding_institution":"University of Tehran","doi":"10.1101\/2019.12.28.19016022","date":"2020-01-02","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"psychiatry and clinical psychology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/01\/02\/2019.12.28.19016022.source.xml","abstract":"Due to the importance of automatic and early autism screening, in this paper, a cry-based screening approach for children with Autism Spectrum Disorder (ASD) is introduced. During the study, we realized that the ASD specific features are not necessarily observable among all children with ASD and among all instances of each child. Therefore, we proposed a new classification approach to be able to find such features and their corresponding instances. We tested the proposed approach and found two features that can be used to distinguish groups of children with ASD from Typically Developing (TD) children. In other words, these features are present in subsets of children with ASD not all of them. The approach has been tested on a dataset including 14 boys and 7 girls with ASD and 14 TD boys and 7 TD girls, between 18 to 53 months old. The sensitivity, specificity, and precision of the proposed approach for boys were 85.71%, 100%, and 92.85%, respectively. These measures were 71.42%, 100%, and 85.71% for girls, respectively.","funder":"NA","published":"10.1371\/journal.pone.0241690","server":"medRxiv"},{"title":"Heterogeneity and heterotypic continuity of emotional and behavioral profiles across development","authors":"Picoito, J.; Santos, C.; Nunes, C.","author_corresponding":"Joao Picoito","author_corresponding_institution":"Centro Hospitalar e Universitario de Coimbra","doi":"10.1101\/2019.12.26.19015917","date":"2020-01-02","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"psychiatry and clinical psychology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/01\/02\/2019.12.26.19015917.source.xml","abstract":"PurposeTo identify emotional and behavioural symptoms profiles from early childhood to adolescence, their stability across development and associated factors.\n\nMethodsOur sample included 17,216 children assessed at ages 3, 5, 7, 11 and 14 years from the UK Millennium Cohort Study. We used latent profile and latent transition analysis to study their emotional and behavioural profiles from early childhood to adolescence. We included sociodemographic, family and parenting variables to study the effect on latent profile membership and transitions.\n\nResultsThe number and specific profiles of emotional and behavioural symptoms changed with the developmental stage. We found a higher number of profiles for ages 3, 5, and 14, suggesting greater heterogeneity in the presentation of emotional and behavioural symptoms in early childhood and adolescence compared to late childhood. There was greater heterotypic continuity between ages 3 and 5, particularly in transitions from higher to lower severity profiles. Children exposed to socioeconomic disadvantages were more likely to belong or transition to any moderate or high emotional and behavioural symptoms profiles. Maternal psychological distress and harsh parenting were associated with internalizing and externalizing profiles, respectively. Higher levels of internalizing and externalizing symptoms across development were associated with lower mental wellbeing and higher rates of self-harm and substance use in adolescence.\n\nConclusionEmotional and behavioural symptoms develop early in life, with levels of heterogeneity and heterotypic stability that change throughout development. These results call for interventions to prevent and treat paediatric mental illness that consider the heterogeneity and stability of symptoms across development.","funder":"NA","published":"10.1007\/s00127-020-01903-y","server":"medRxiv"},{"title":"The use of wearable technology to objectively measure sleep quality and physical activity among pregnant women in urban Lima, Peru: A pilot feasibility study","authors":"Galea, J. T.; Ramos, K.; Coit, J.; Friedman, L. R.; Contreras, C.; Duenas, M.; Hernandez, G. N.; Muster, C.; Lecca, L.; Gelaye, B.","author_corresponding":"Jerome T. Galea","author_corresponding_institution":"University of South Florida","doi":"10.1101\/2019.12.29.19016097","date":"2020-01-02","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"public and global health","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/01\/02\/2019.12.29.19016097.source.xml","abstract":"Sleep quality and physical activity can affect the mental and physical health of pregnant women and their unborn babies. We investigated the feasibility of assessing sleep quality and physical activity among pregnant women in Peru. Twenty women maintained sleep logs and wore ActiSleep devices for seven consecutive days; 13 had sufficient data for analysis. Mean sleep duration was 6.9 hours (SD = 1.4). Sleep efficiency was 77.9%. Participants averaged of 6,029 steps per day (SD = 3,087). Objective assessment of sleep quality and physical activity was feasible. Wearable technology has applications in healthcare to improve sleep quality and physical activity.","funder":"NA","published":"10.1007\/s10995-020-02931-5","server":"medRxiv"},{"title":"Interprofessional Learning in Immediate Life Support training improves simulated patient related outcomes.","authors":"Morse, J. C.; Brown, C. W.","author_corresponding":"Jeremy C Morse","author_corresponding_institution":"University of Aberdeen","doi":"10.1101\/2019.12.31.19016170","date":"2020-01-02","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"medical education","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/01\/02\/2019.12.31.19016170.source.xml","abstract":"Aim of the studyTo assess team performance in implementing time critical key interventions during a simulated resuscitation after participating in either an interprofessional-learning (IPL) or uniprofessional-learning (UPL) Immediate Life Support training course (ILS).\n\nIntroductionMuch of the published work on team-based simulation training has measured the lower levels of Kirkpatricks hierarchy of evidence and effectiveness. This study aimed to ascertain if interprofessional team training could improve a higher level of outcome such as behaviour and patient outcomes.\n\nMethodsA retrospective quantitative analysis of time critical points in a simulated cardiac arrest resuscitation, from a previous randomised study on the effects of Interprofessional Learning in ILS. The video recordings from the original study consisting of medical (n=48) and nursing (n=48) students were analysed to mark when either the IPL or UPL team performed a time critical intervention.\n\nResultsFive time-critical points for interventions were identified; confirmation of cardiac arrest, commencement of initial CPR, rhythm check, time to 1st shock and delay in restarting CPR. Parametric testing of each of these time-based criteria were subjected to an independent sample t-test with statistically significant findings in three of the five criteria in favour of those who had undertaken the interprofessional learning.\n\nConclusionOur results demonstrate that through an IPL approach in ILS there was a statistically different improvement in mean times to performing time-critical interventions, which if transferred to the clinical environment could improve and impact on both change of behaviour and patient outcomes in Kirkpatricks higher levels of evidence and effectiveness.\n\nThough this study shows that team behaviour and performing time-critical interventions can improve in the short-term, we acknowledge that further longitudinal studies are required to ascertain the effect of such improvement over time. So that both as researchers and educators we can make healthcare teams work safer and more efficiently to improve patient outcomes.\n\nO_TEXTBOXWhat this paper addsO_ST_ABSWhat is already knownC_ST_ABSLike simulation, intuitively we know that Interprofessional Learning and Team training should make a difference to clinical practice for those involved. The majority of research reported, is measured at the lower levels of Kirkpatricks hierarchy. This retrospective video analysis of a previous study aimed to look at the functioning between interprofessionally and uni-professionally trained teams in performing time-critical interventions in a simulated cardiac arrest.\n\nWhat this study addsOur study suggests that the use of Interprofessional Learning in resuscitation training does have an effect on performance during the management of a simulated cardiac arrest which could improve and impact on both change of behaviour and patient outcomes in Kirkpatricks higher levels of evidence and effectiveness.\n\nC_TEXTBOX","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Automatic detection of generalized paroxysmal fast activity in Lennox-Gastaut syndrome using a bi-modal EEG time-frequency feature","authors":"Omidvarnia, A.; Warren, A. E. L.; Dalic, L. L.; Pedersen, M.; Archer, J. S.; Jackson, G. D.","author_corresponding":"Amir Omidvarnia","author_corresponding_institution":"The Florey Institute of Neuroscience and Mental Health,The University of Melbourne","doi":"10.1101\/2019.12.28.19016089","date":"2020-01-02","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc","category":"neurology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/01\/02\/2019.12.28.19016089.source.xml","abstract":"ObjectiveMark-up of generalized interictal epileptiform discharges (IEDs) on EEG is an important step in the diagnosis and characterization of epilepsy. However, manual EEG mark-up is a time-consuming, subjective, and highly specialized task where the human reviewer needs to visually inspect a large amount of data to facilitate accurate clinical decisions. The objective of this study was to develop a framework for automated detection of generalized paroxysmal fast activity (GPFA), which is a characteristic type of generalized IED seen in scalp EEG recordings of patients with Lennox-Gastaut syndrome (LGS), a severe form of drug-resistant generalized epilepsy.\n\nMethodsWe studied 13 children with LGS who had GPFA events in their interictal EEG recordings. Time-frequency information derived from manually marked IEDs across multiple EEG channels was used to automatically detect similar events in each patients interictal EEG. We validated true positives and false positives of the proposed spike detection approach using both standalone scalp EEG and simultaneous EEG-functional MRI (EEG-fMRI) recordings.\n\nResultsGPFA events displayed a consistent low-high frequency arrangement in the time-frequency domain. This  bi-modal spectral feature was most prominent over frontal EEG channels. Our automatic detection approach using this feature identified likely epileptic events with similar time-frequency properties to the manually marked GPFAs. Brain maps of EEG-fMRI signal change during these automatically detected IEDs were comparable to the EEG-fMRI brain maps derived from manual IED mark-up.\n\nConclusionGPFA events have a characteristic bi-modal time-frequency feature that can be automatically detected from scalp EEG recordings in patients with LGS. Validity of this time-frequency feature is demonstrated by EEG-fMRI analysis of automatically detected events, which recapitulates the brain maps we have previously shown to underlie generalized IEDs in LGS.\n\nSignificanceThis study provides a novel methodology that paves the way for quick, automated, and objective inspection of generalized IEDs in LGS. The proposed framework may be extendable to a wider range of epilepsy syndromes in which monitoring the burden of epileptic activity can aid clinical decision-making. For example, automated quantification of generalized discharges may permit faster assessment of treatment response and estimation of future seizure risk.","funder":"NA","published":"10.1016\/j.compbiomed.2021.104287","server":"medRxiv"},{"title":"A new incidence peak of childhood narcolepsy type 1 in 2013:a new perspective on the role of influenza virus?","authors":"Zhang, Z.; Gool, J.; Fronczek, R.; Bassetti, C. L.; Dauvilliers, Y.; Mayer, G.; Plazzi, G.; Pizza, F.; Santamaria, J.; Partinen, M.; Overeem, S.; Peraita-Adrados, R.; da Silva, A. M.; Sonka, K.; del Rio-Villegas, R.; Heinzer, R.; Wierzbicka, A.; Young, P.; Ho\u0308gl, B.; Manconi, M.; Feketeova, E.; Mathis, J.; Paiva, T.; Canellas, F.; Lecendreux, M.; Baumann, C. R.; Barateau, L.; Pesenti, C.; Antelmi, E.; Gaig, C.; Iranzo, A.; Lillo-Triguero, L.; Medrano-Martinez, P.; Haba-Rubio, J.; Gorban, C.; Lammers, G.-J.; Khatami, R.","author_corresponding":"Zhongxing Zhang","author_corresponding_institution":"Clinic Barmelweid AG","doi":"10.1101\/2019.12.31.19016246","date":"2020-01-02","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"neurology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/01\/02\/2019.12.31.19016246.source.xml","abstract":"Increased incidence rates of narcolepsy type 1 (NT1) after the 2009-2010 H1N1 influenza pandemic (pH1N1) have been reported world-wide. While some European countries found an association between the NT1 increase and H1N1 vaccination Pandemrix, reports from Asian countries suggested the H1N1 virus rather than Pandemrix to be linked with the increase of new NT1 cases. We analyzed the number of de-novo NT1 cases in the last two decades until 2016 using the European Narcolepsy Network (EU-NN) database. Using robust data-driven modelling approaches we confirmed the peak of NT1 incidence in 2009-2010 pH1N1 and identified a new peak in 2013 that is age-specific for children\/adolescents. Most of these de-novo cases showed a subacute disease onset consistent with an immune-mediated type of narcolepsy, which is most likely not related to Pandemrix vaccination that was used in 2009-2010, but may have been triggered by some new epidemiological event in Europe. Our finding of an unexpected peak in de-novo children narcolepsy in 2013 provides a unique opportunity to develop new hypotheses, such as considering other (influenza) viruses to further investigate the pathophysiology of immune-mediated narcolepsy.","funder":"NA","published":"10.1093\/sleep\/zsaa172","server":"medRxiv"},{"title":"Neuromagnetic speech discrimination responses are associated with reading-related skills in dyslexic and typical readers","authors":"Thiede, A.; Parkkonen, L.; Virtala, P.; Laasonen, M.; Makela, J. P.; Kujala, T.","author_corresponding":"Anja Thiede","author_corresponding_institution":"University of Helsinki","doi":"10.1101\/2019.12.29.19016113","date":"2020-01-02","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"neurology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/01\/02\/2019.12.29.19016113.source.xml","abstract":"Dyslexia is thought to result from poor phonological processing. We investigated neuromagnetic speech discrimination in dyslexic and typical readers with mismatch fields (MMF) and determined the associations between MMFs and reading-related skills. We expected weak and atypically lateralized MMFs in dyslexic readers, and associations between reading-related skills and MMF strength. MMFs were recorded to a repeating pseudoword \/ta-ta\/ with occasional changes in vowel identity, duration, or syllable frequency from 43 adults, 21 with confirmed dyslexia. Speech-sound changes elicited MMFs in bilateral auditory cortices, with no group differences in source strengths. MMFs to vowel identity and duration changes were left-lateralized. Better verbal working memory was associated with stronger left-hemispheric MMFs across groups, suggesting the relevance of verbal working memory for speech processing. Better technical reading was associated with stronger right-hemispheric MMFs in dyslexic readers, suggesting a right-hemispheric compensatory mechanism for language processing. In conclusion, contrary to prior work, our results did not support deficient speech discrimination in dyslexia. However, in line with previous studies, we observed left-lateralized MMFs to vowel identity and duration changes, and associations of MMFs with reading-related skills, highlighting the connection between neural speech processing and reading and promoting the use of MMFs in investigating reading-related brain processes.\n\nHighlightsO_LISpeech-sound changes elicit comparable mismatch fields in dyslexics and controls.\nC_LIO_LIMismatch fields (MMFs) to vowel identity and duration changes are left-lateralized.\nC_LIO_LIStronger left MMFs are associated with better verbal working memory across groups.\nC_LIO_LIStronger right MMFs are associated with better technical reading in dyslexics.\nC_LIO_LILow-level neural speech discrimination is associated with reading-related skills.\nC_LI","funder":"NA","published":"10.1016\/j.heliyon.2020.e04619","server":"medRxiv"},{"title":"Galantamine alleviates oxidative stress alongside anti-inflammatory and cardio-metabolic effects in subjects with the metabolic syndrome in a randomized trial","authors":"Sangaleti, C. T.; Katayama, K. Y.; De Angelis, K.; de Moraes, T. L.; Araujo, A. A.; Lopes, H. F.; Camacho, C.; Bortolotto, L. A.; Michelini, L. C.; Irigoyen, M. C.; Barnaby, D. P.; Tracey, K. J.; Pavlov, V. A.; Consolim Colombo, F. M.","author_corresponding":"Valentin A. Pavlov","author_corresponding_institution":"The Feinstein Institutes for Medical Research","doi":"10.1101\/2019.12.30.19016105","date":"2020-01-02","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"endocrinology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/01\/02\/2019.12.30.19016105.source.xml","abstract":"BackgroundThe metabolic syndrome (MetS) is an obesity-driven disorder with pandemic proportions and limited treatment options. Oxidative stress, low-grade inflammation and altered autonomic regulation, are important components of MetS pathophysiology. We recently reported that galantamine, an acetylcholinesterase inhibitor and an FDA-approved drug (for Alzheimers disease) alleviates the inflammatory state in MetS subjects. Here we examined the effects of galantamine on oxidative stress in parallel with inflammatory and cardio-metabolic parameters in subjects with MetS.\n\nMethodsThe effects of galantamine treatment, 8 mg daily for 4 weeks, followed by 16 mg daily for 8 weeks or placebo were studied in randomly assigned subjects with MetS (n=22 per group) of both genders. Oxidative stress, including superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase activities, lipid and protein peroxidation, and nitrite levels were analyzed before and at the end of the treatment. In addition, plasma cytokine and adipokine levels, insulin resistance (HOMA-IR) and other relevant cardio-metabolic indices were analyzed. Autonomic regulation was also examined by heart rate variability (HRV) before treatment, and at every 4 weeks of treatment.\n\nResultsGalantamine treatment significantly increased antioxidant enzyme activities, including SOD (+1.65 USOD\/mg protein, [95% CI 0.39 to 2.92], P=0.004) and CAT (+0.93 nmol\/mg, [95% CI 0.34 to 1.51], P=0.011), decreased lipid peroxidation (thiobarbituric acid reactive substances, -5.45 pmol\/mg, [95% CI -10.97 to 0.067], P=0.053) and systemic nitrite levels (-0.05 nit\/mg protein, [95% CI -0.21 to 0.10], P=0.038) compared with placebo. In addition, galantamine significantly alleviated the inflammatory state and insulin resistance, and decreased the low frequency\/high frequency ratio of HRV, following 8 and 12 weeks of drug treatment.\n\nConclusionLow-dose galantamine alleviates oxidative stress, alongside beneficial anti-inflammatory, and metabolic effects, and modulates autonomic regulation in subjects with MetS. These findings are of considerable interest for further studies with galantamine to ameliorate MetS pathophysiology.","funder":"NA","published":"10.3389\/fimmu.2021.613979","server":"medRxiv"},{"title":"Is e-cigarette use in non-smoking young adults associated with later smoking? A systematic review and meta-analysis","authors":"Khouja, J. N.; Suddell, S. F.; Peters, S. E.; Taylor, A. E.; Munafo, M. R.","author_corresponding":"Jasmine N Khouja","author_corresponding_institution":"University of Bristol","doi":"10.1101\/19007005","date":"2020-01-02","version":"2","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/01\/02\/19007005.source.xml","abstract":"ObjectiveThe aim of this review was to investigate whether e-cigarette use compared to non-use in young non-smokers is associated with subsequent cigarette smoking.\n\nData sourcesPubMed, Embase, Web of Science, Wiley Cochrane Library databases, and the 2018 Society for Research on Nicotine and Tobacco and Society for Behavioural Medicine conference abstracts.\n\nStudy selectionAll studies of young people (up to age 30 years) with a measure of e-cigarette use prior to smoking and an outcome measure of smoking where an odds ratio could be calculated were included (excluding reviews and animal studies).\n\nData ExtractionIndependent extraction was completed by multiple authors using a pre-prepared extraction form.\n\nData synthesisOf 9,199 results, 17 studies were included in the meta-analysis. There was strong evidence for an association between e-cigarette use among non-smokers and later smoking (OR 4.59, 95% CI 3.60 to 5.85) when the results were meta-analysed in a random effects model. However, there was high heterogeneity (I2 = 88%).\n\nConclusionsWhilst the association between e-cigarette use among non-smokers and subsequent smoking appears strong, the available evidence is limited by the reliance on self-report measures of smoking history without biochemical verification. None of the studies included negative controls which would provide stronger evidence for whether the association may be causal. Much of the evidence also failed to consider the nicotine content of e-liquids used by non-smokers meaning it is difficult to make conclusions about whether nicotine is the mechanism driving this association.","funder":"NA","published":"10.1136\/tobaccocontrol-2019-055433","server":"medRxiv"},{"title":"A genomic epidemiology investigation of yaws re-emergence and bacterial drug resistance selection","authors":"Beale, M. A.; Noguera-Julian, M.; Godornes, C.; Casadella, M.; Gonzalez-Beiras, C.; Parera, M.; Corbacho-Monne, M.; Paredes, R.; Gonzalez-Candelas, F.; Marks, M.; Lukehart, S. A.; Thomson, N. R.; Mitja, O.","author_corresponding":"Mathew A Beale","author_corresponding_institution":"Wellcome Sanger Institute","doi":"10.1101\/2019.12.31.19016220","date":"2020-01-02","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/01\/02\/2019.12.31.19016220.source.xml","abstract":"BackgroundIn a longitudinal study assessing the WHO strategy for yaws eradication using mass azithromycin treatment, we observed resurgence of yaws cases with dominance of a single JG8 sequence type and emergence of azithromycin-resistant Treponema pallidum. Here, we analyse genomic changes in the bacterial population using samples collected during the study.\n\nMethodsWe performed whole bacterial genome sequencing directly on DNA extracted from 37 lesion swabs collected from patients on Lihir Island, Papua New Guinea, between 2013 and 2016. We produced phylogenies and correlated these with temporo-spatial information to investigate the source of new cases and the emergence of five macrolide-resistant cases. We used deep amplicon sequencing of surveillance samples to assess the presence of minority macrolide resistance populations.\n\nFindingsWe recovered 20 whole Treponema genomes, and phylogenetic analysis showed that the re-emerging JG8 sequence type was composed of three bacterial sub-lineages characterised by distinct temporo-spatial patterns. Of five patients with resistant Treponema, all epidemiologically linked, we recovered genomes from three and found no variants. Deep sequencing showed that pre-treatment, the index patient harboured fixed macrolide-sensitive Treponema, while the post-treatment sample harboured a fixed resistant genotype, as did three of four contact cases. We also found no evidence of pre-existing minority Treponema drug-resistance variants in the general population.\n\nInterpretationIn this study, re-emergence of yaws cases was polyphyletic, indicating multiple epidemiological sources. However, given the genomic and epidemiological linkage of resistant cases and the rarity of resistance alleles in the general population, it is likely that azithromycin resistance evolved only once in this study, followed by onward dissemination.\n\nFundingWellcome (Grant #206194), Provintial Deputation of Barcelona (Grant #1940000465).\n\nResearch in contextO_ST_ABSEvidence before this studyC_ST_ABSWe searched PubMed using the terms \"yaws\", \"Treponema pallidum\", \"mass treatment\", and \"azithromycin\", without date or language restrictions. Mass drug administration (MDA) using azithromycin (single-dose 30 mg\/kg, maximum 2 g) has been a successful strategy to reduce yaws prevalence in endemic communities, with trials conducted in both Papua New Guinea and Ghana. However, there are no long-term follow-up studies other than in Papua New Guinea, where a resurgence of yaws cases was observed 24-months after MDA. Multilocus sequence typing (MLST) showed a change in Treponema pallidum subspecies pertenue (TPE) to a single dominant JG8 type, and identified resistant strains with the same MLST type, but this method lacked the resolution to determine the epidemiological mechanism leading to yaws re-emergence and how macrolide resistance manifested.\n\nAdded value of this studyThis study is the first to use whole genome sequencing (WGS) for a detailed investigation of TPE transmission and to apply deep amplicon sequencing to TPE macrolide resistance mutations. Leveraging the increased resolution of WGS over other techniques, we show that re-emergence of yaws after MDA was the result of at least three distinct bacterial sub-lineages with different temporo-spatial properties (likely due to several infected people missing treatment) rather than a single point-source. WGS also shows that patients with macrolide-resistant yaws had genomically indistinguishable TPE, indicating a recent common ancestor, and possibly a recent chain of transmission originating from the index case. Deep amplicon sequencing corroborates that PCR-tested macrolide sensitive samples do not harbour resistant minority populations at detectable levels.\n\nImplications of all the available evidenceOur data suggest yaws re-emergence after MDA was driven by multiple sources, and therefore we recommend higher population coverage and intensive post-MDA surveillance. These data show resistance likely evolved once during the trial, rather than being widespread. We recommend careful monitoring of affected communities during post-MDA follow-up in order to rapidly detect new emergence of azithromycin resistance, and consideration for using alternative treatments for cases detected post-MDA.","funder":"NA","published":"10.1016\/S2666-5247(20)30113-0","server":"medRxiv"},{"title":"Surgical candidacy and treatment uptake among women with cervical cancer at public referral hospitals in Kampala, Uganda","authors":"Swanson, M.; MIRIAM, N.; Chen, L.-m.; Ueda, S.; Namugga, J.; Nakisige, C.; Huchko, M. J.","author_corresponding":"Megan Swanson","author_corresponding_institution":"University of California San Francisco","doi":"10.1101\/2019.12.31.19016279","date":"2020-01-03","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"oncology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/01\/03\/2019.12.31.19016279.source.xml","abstract":"PurposeCervical cancer is the most common malignancy among women in Uganda. Most present with advanced disease, when hysterectomy is not possible and cure is less likely. This study reports the proportion recommended for hysterectomy and associated factors, recommended treatments by stage, and treatment uptake.\n\nMethodsWe conducted a prospective study among patients seeking care for cervical cancer at public referral hospitals in Uganda. In-person surveys were followed by a phone call. Descriptive and multivariate statistical analyses examined associations between predictors and outcomes.\n\nResultsAmong 268 participants, 76% were diagnosed at an advanced stage (IIB-IVB). In total, 12% were recommended for hysterectomy. In adjusted analysis, living within 15 kilometers of Kampala (OR 3.10, 95% CI 1.20-8.03) and prior screening (OR 2.89, 95% CI 1.22-6.83) were significantly associated with surgical candidacy. Radiotherapy availability was not significantly associated with treatment recommendations for early-stage (IA-IIA) disease, but was associated with recommended treatment modality (chemo-radiation versus primary chemotherapy) for locally advanced stage (IIB-IIIB). Most (67%) had started treatment. No demographic or health factor, treatment recommendation, or radiation availability was associated with treatment initiation. Among those recommended for hysterectomy, 55% underwent surgery. Among those who had initiated treatment, 82% started the modality that was actually recommended.\n\nConclusionWomen presented to public referral centers in Kampala with mostly advanced-stage cervical cancer and few were recommended for surgery. Lack of access to radiation did not significantly increase the proportion of early-stage cancers recommended for hysterectomy.","funder":"NA","published":"10.1136\/bmjopen-2020-039946","server":"medRxiv"},{"title":"Sensitive detection of tumor mutations from blood and its application to immunotherapy prognosis","authors":"Li, S.; Noor, Z.; Zeng, W.; Ni, X.; Yuan, Z.; Alber, F.; Li, W.; Garon, E. B.; Zhou, X.","author_corresponding":"Xianghong Zhou","author_corresponding_institution":"University of California, Los Angeles","doi":"10.1101\/2019.12.31.19016253","date":"2020-01-03","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"genetic and genomic medicine","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/01\/03\/2019.12.31.19016253.source.xml","abstract":"Liquid biopsy using cell-free DNA (cfDNA) is attractive for a wide range of clinical applications, including cancer detection, locating, and monitoring. However, developing these applications requires precise and sensitive calling of somatic single nucleotide variations (SNVs) from cfDNA sequencing data. To date, no SNV caller addresses all the special challenges of cfDNA to provide reliable results. Here we present cfSNV, a revolutionary somatic SNV caller with five innovative techniques to overcome and exploit the unique properties of cfDNA. cfSNV provides hierarchical mutation profiling, thanks to cfDNAs complete coverage of the clonal landscape, and multi-layer error suppression. In both simulated datasets and real patient data, we demonstrate that cfSNV is superior to existing tools, especially for low-frequency somatic SNVs. We also show how the five novel techniques contribute to its performance. Further, we demonstrate a clinical application using cfSNV to select non-small-cell lung cancer patients for immunotherapy treatment.","funder":"NA","published":"10.1038\/s41467-021-24457-2","server":"medRxiv"},{"title":"Novel FARS2 mutations in patients with non-fatal early onset encephalopathy with or without epilepsy","authors":"Barcia, G.; Rio, M.; Assouline, Z.; Zangarelli, C.; Roux, C.-J.; de Lonlay, P.; Steffann, J.; Desguerre, I.; Munnich, A.; Bonnefont, J.-P.; Boddaert, N.; Ro\u0308tig, A.; Metodiev, M. D.; Ruzzenente, B.","author_corresponding":"Benedetta Ruzzenente","author_corresponding_institution":"Laboratory for Genetics of Mitochondrial Disorders, UMR U1163, Paris Descartes-Sorbonne Paris Cit\u00e9 University, Imagine Institute, Paris, France.","doi":"10.1101\/2019.12.30.19016139","date":"2020-01-03","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"genetic and genomic medicine","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/01\/03\/2019.12.30.19016139.source.xml","abstract":"Mitochondrial translation is essential for the biogenesis of the mitochondrial oxidative phosphorylation system (OXPHOS) that synthesizes the bulk of ATP for the cell. Hypomorphic and loss-of-function variants in either mitochondrial DNA or in nuclear genes that encode mitochondrial translation factors can result in impaired OXPHOS biogenesis and mitochondrial diseases with variable clinical presentations.\n\nCompound heterozygous or homozygous missense and frameshift variants in the FARS2 gene, that encodes the mitochondrial phenylalanyl-tRNA synthetase, are commonly linked to either early-onset epileptic mitochondrial encephalopathy or spastic paraplegia. Here, we expand the genetic spectrum of FARS2-linked disease with three patients carrying novel compound heterozygous variants in the FARS2 gene and presenting with spastic tetraparesis, axial hypotonia and myoclonic epilepsy in two cases.","funder":"NA","published":"10.1038\/s41431-020-00757-x","server":"medRxiv"},{"title":"Exploiting the Reverse Vaccinology Approach to Design Novel Subunit Vaccine against Ebola Virus","authors":"Ullah, M. A.; Sarkar, B.; Islam, S. S.","author_corresponding":"Md. Asad Ullah","author_corresponding_institution":"Jahangirnagar University","doi":"10.1101\/2020.01.02.20016311","date":"2020-01-03","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"allergy and immunology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/01\/03\/2020.01.02.20016311.source.xml","abstract":"Ebola virus is a highly pathogenic RNA virus that causes haemorrhagic fever in human. With very high mortality rate, Ebola virus is considered as one of the dangerous viruses in the world. Although, the Ebola outbreaks claimed many lives in the past, no satisfactory treatment or vaccine have been discovered yet to fight against Ebola. For this reason, in this study, various tools of bioinformatics and immunoinformatics were used to design possible vaccines against Zaire Ebola virus strain Mayinga-76. To construct the vaccine, three potential antigenic proteins of the virus, matrix protein VP40, envelope glycoprotein and nucleoprotein were selected against which the vaccines would be designed. The MHC class-I, MHC class-II and B-cell epitopes were determined and after robust analysis through various tools and molecular docking analysis, three vaccine candidates, designated as EV-1, EV-2 and EV-3, were constructed. Since the highly conserved epitopes were used for vaccine construction, these vaccine constructs are also expected to be effective on other strains of Ebola virus like strain Gabon-94 and Kikwit-95. Next, the molecular docking study on these vaccine constructs were analyzed by molecular docking study and EV-1 emerged as the best vaccine construct. Later, molecular dynamics simulation study revealed the good performances as well as good stability of the vaccine protein. Finally, codon adaptation and in silico cloning were conducted to design a possible plasmid (pET-19b plasmid vector was used) for large scale, industrial production of the EV-1 vaccine.","funder":"NA","published":"10.1016\/j.imbio.2020.151949","server":"medRxiv"},{"title":"Dissecting the mechanisms of a 5-year decline in antibiotic prescribing","authors":"Kissler, S. M.; Klevens, R. M.; Barnett, M. L.; Grad, Y. H.","author_corresponding":"Yonatan H. Grad","author_corresponding_institution":"Harvard T.H. Chan School of Public Health","doi":"10.1101\/2020.01.02.20016329","date":"2020-01-03","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc0","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/01\/03\/2020.01.02.20016329.source.xml","abstract":"ImportanceThe mechanisms driving the recent decline in outpatient antibiotic prescribing are unknown.\n\nObjectiveTo estimate the extent to which reductions in the number of antibiotic prescriptions filled per outpatient visit (stewardship) and reductions in the monthly rate of outpatient visits (observed disease) for infectious disease conditions each contributed to the decline in annual outpatient antibiotic prescribing rate in Massachusetts between 2011 and 2015.\n\nDesignOutpatient medical and pharmacy claims from the Massachusetts All-Payer Claims Database were used to estimate rates of antibiotic prescribing and outpatient visits for 20 medical conditions and their contributions to the overall decline in antibiotic prescribing. Trends were compared to those in the National Ambulatory Medical Care Survey (NAMCS).\n\nSettingOutpatient visits in Massachusetts between January 2011 and September 2015.\n\nParticipants5,075,908 individuals with commercial health insurance or Medicaid in Massachusetts under the age of 65 and 495,515 patients included in NAMCS.\n\nMain outcomes and measuresThe number of antibiotic prescriptions avoided through reductions in observed disease and reductions in per-visit prescribing rate per medical condition.\n\nResultsBetween 2011 and 2015, the January antibiotic prescribing rate per 1,000 individuals in Massachusetts declined by 18.9% and the July antibiotic prescribing rate declined by 13.6%. The mean prescribing rate for children under 5 declined by 42.8% (95% CI 21.7%, 59.4%), principally reflecting reduced wintertime prescribing. The monthly rate of outpatient visits per 1,000 individuals in Massachusetts declined (p < 0.05) for respiratory infections and urinary tract infections. Nationally, visits for medical conditions that merit an antibiotic prescription also declined between 2010 and 2015. Of the estimated 358 antibiotic prescriptions per 1,000 individuals avoided over the study period in Massachusetts, 59% (95% CI 54%, 63%) were attributable to reductions in observed disease and 41% (95% CI 37%, 46%) to reductions in prescribing per outpatient visit.\n\nConclusions and relevanceThe decline in antibiotic prescribing in Massachusetts was driven by a decline in observed disease and improved antibiotic stewardship, with a contemporaneous reduction in visits for conditions prompting antibiotics observed nationally. A focus on infectious disease prevention should be considered alongside antibiotic stewardship as a means to reduce antibiotic prescribing.\n\nKey pointsO_ST_ABSQuestionC_ST_ABSHow did the separate mechanisms of improved stewardship and reductions in observed disease contribute to a 5-year decline in outpatient antibiotic prescribing in Massachusetts from 2011-2015?\n\nFindingsIn an observational analysis of insurance claims, reduced monthly rates of outpatient visits for infectious conditions and reduced probability of prescribing an antibiotic per outpatient visit both contributed to the decline in antibiotic prescribing. An estimated 358 antibiotic prescriptions per 1,000 individuals were avoided over the study period through the two mechanisms, 211 of which were attributable to reductions in outpatient visits and 147 to reduced antibiotic prescribing per visit.\n\nMeaningPreventing the need for outpatient visits should be considered alongside antibiotic stewardship as a means of reducing antibiotic prescribing.","funder":"NA","published":"10.1093\/cid\/ciaa269","server":"medRxiv"},{"title":"Polygenic Risk for Depression is Associated with the Severity and Rate of Change in Depressive Symptoms Across Adolescence","authors":"Kwong, A. S. F.; Morris, T. T.; Timpson, N. J.; Pearson, R. M.; Rice, F.; Stergiakouli, E.; Tilling, K.","author_corresponding":"Alex S. F. Kwong","author_corresponding_institution":"University of Bristol","doi":"10.1101\/2019.12.31.19016212","date":"2020-01-03","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/01\/03\/2019.12.31.19016212.source.xml","abstract":"Adolescence marks a period where depression will commonly onset and previous research using twin studies has suggested that genetic influences play a role in how depression develops and changes across adolescence. Recent genome-wide association studies have also shown that common genetic variants - which can be combined into a polygenic risk score (PRS) - are also implicated in depression. However, the role of PRS in adolescent depression and changes in adolescent depression is not yet understood. We aimed to examine the association between a PRS for depressive symptoms and depressive symptoms across adolescence and young adulthood, and how polygenic risk is associated with changes in depressive symptoms using two methods: cross-sectional analysis and multilevel growth curve modelling to examine the rate of change over time. Using data from over 6000 participants of the Avon Longitudinal Study of Parents and Children (ALSPAC) we examined associations between genetic liability to depressive symptoms (PRS for depressive symptoms) and self-reported depressive symptoms (short mood and feelings questionnaire over 9 occasions from 10-24 years). We examined cross-sectional associations at each age and longitudinal trajectories of depressive symptoms in a repeated measures framework using growth curve analysis. The PRS was associated with depressive symptoms throughout adolescence and young adulthood in cross-sectional and growth curve analyses, though associations were stronger in the latter analyses. Growth curve analyses also provided additional insights, demonstrating that individuals with a higher PRS had steeper trajectories of depressive symptoms across adolescence with a greater increasing rate of change. These results show that common genetics variants as indexed by a PRS for depressive symptoms influence both the severity and rate of change in adolescent depressive symptoms. Longitudinal data that make use of repeated measures designs have the potential to provide greater insights into the factors that influence the onset and persistence of adolescent depression.","funder":"NA","published":"10.1111\/jcpp.13422","server":"medRxiv"},{"title":"Prevalence, Characteristics, and Associated Factors of Workplace Violence Against Healthcare Professionals in India: A Systematic Review and Meta-analysis","authors":"Hossain, M. M.; Sharma, R.; Tasnim, S.; Kibria, G. M. A.; Sultana, A.; Saxena, T.","author_corresponding":"Md Mahbub Hossain","author_corresponding_institution":"Texas A&M School of Public Health","doi":"10.1101\/2020.01.01.20016295","date":"2020-01-03","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"public and global health","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/01\/03\/2020.01.01.20016295.source.xml","abstract":"BackgroundWorkplace violence (WPV) against doctors, nurses, and other healthcare professionals is a growing public health concern affecting health systems in low- and middle-income countries. In India, incidents of WPV against health workforce have become common in recent years. However, there is no synthesized evidence on the nationwide burden of WPV in healthcare. This study aims to systematically evaluate the current evidence on the prevalence, characteristics, and associated factors of WPV against healthcare professionals in India.\n\nMethodsWe systematically searched seven major databases and additional sources to retrieved published literature on WPV in India. We included empirical studies without any time restriction, which reported the prevalence of WPV against healthcare professionals in India. Following data extraction, we estimated the pooled prevalence of WPV using random-effects model in meta-analysis. The characteristics and associated factors of WPV were narratively synthesized from these empirical studies.\n\nResultsAmong 1065 articles retrieved from multiple sources, 15 studies met our inclusion and exclusion criteria. The pooled prevalence of WPV among 2849 participants in those 15 studies was 63% (95% confidence interval [CI], 54%-72%). In the subgroup analyses, the pooled prevalence for male and female was 64% (95% CI, 51%-78%) and 54% (95% CI, 47%-62%) respectively. Moreover, pooled prevalence in 12-months and lifetime was 55% (95% CI, 43%-67%) and 69% (95% CI, 61%-78%) respectively. Among the participants, the prevalence of verbal violence (52%; 95% CI, 45%-60%) was higher than physical violence (8%; 95% CI, 5%-11%). The emergency department was a common location of WPV, whereas the patients attendants were perpetrators in most studies. Major factors associated with WPV included ineffective patient-provider communication, less experience of the healthcare professionals, overcrowding, shortage of resources, long waiting hours, lack of security measures, dissatisfaction about health services, high cost of care, the negative role of media, and other socio-behavioral problems among the patients and healthcare professionals.\n\nConclusionWPV is highly prevalent among healthcare professionals in India. Critical challenges within the healthcare and social context necessitate further research, better policymaking, and multipronged interventions to address the same and prevent WPV against healthcare professionals in India.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"The role of Body Mass Index in high and low velocity trauma causing knee injury associated to popliteal artery lesions.","authors":"Ascoli Marchetti, A.; Naldi, V.; Oddi, F. M.; De Maio, F.; Citoni, G. C.; Potenza, V.; Farsetti, P.; Ippoliti, A.","author_corresponding":"Andrea Ascoli Marchetti Sr.","author_corresponding_institution":"Vascular Surgery Unit","doi":"10.1101\/2019.12.31.19015966","date":"2020-01-03","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"primary care research","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/01\/03\/2019.12.31.19015966.source.xml","abstract":"BackgroundOsteoarticular traumas are particularly dangerous among arterial traumas, those associated with the popliteal artery are associated with a high amputation rate. Despite representing a minority of arterial traumas, with an incidence that considerably varies by population and geographic location, traumatic lesions of the popliteal artery are a challenge. This study aimed to verify the impact of BMI on arterial trauma damage and outcome.\n\nMethodsData were retrospectively collected from the emergency and operating rooms electronic medical reports at our Institution between 1 January 2005 and 1 May 2018 of all osteoarticular and vascular associated lesion. 41 pts presented with lower limb arterial trauma (43.2%), and popliteal artery lesions occurred in 11 (26.8%). 11 patients were eligible for inclusion in the study. In addition, the lesion mechanism was dislocation by high-velocity trauma in 9 cases and by low-velocity trauma in 3. All 7 males (63.6%) were affected by high-velocity trauma, and 2 of the 3 females by low-velocity trauma. Only one patient had an isolated popliteal artery lesion associated with fractures in the leg or in contralateral limb. Patients with low-velocity traumas were older than 54 years while those with high-velocity were aged from 22 to 71 years.\n\nResultsThe lesion mechanism was dislocation due to high-velocity trauma in eight patients and due to low-velocity trauma in three. In 10\/11 patients (90.9%) revascularization was performed after osteoarticular stabilization. after reduction of the dislocation or fracture. Intraoperative angiography was selectively used. Two patients required above-knee amputation after the procedure: one due to infection of the surgical access and the other due to severe soft tissue injury. One patient died during hospitalization due to trauma-related complications and comorbidities.\n\nConclusionsRevascularization success is not associated with high- or low-velocity traumas. Furthermore, unlike high-velocity traumas, low-velocity traumas are associated with a body mass index >35kg\/m2.","funder":"NA","published":"10.1186\/s13018-024-04821-w","server":"medRxiv"},{"title":"An Efficient and Robust Approach to Detect Auditory Evoked Brainstem Responses using Adaptive Averaging","authors":"Wang, H.; Li, B.; Ding, X.; Wang, X.; Huang, Z.; Wu, H.; Hua, Y.","author_corresponding":"Yunfeng Hua","author_corresponding_institution":"Ear Institute, Shanghai Jiao Tong University School of Medicine","doi":"10.1101\/19003301","date":"2020-01-03","version":"2","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"otolaryngology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/01\/03\/19003301.source.xml","abstract":"Auditory brainstem response (ABR) serves as an objective indication of auditory perception at given sound level and is nowadays widely used in hearing function assessment. Despite efforts for automation over decades, hearing threshold determination by machine algorithm remains unreliable and thereby still rely on visual identification by trained personnel. Here, we described a procedure for automatic threshold determination that can be used in both animal and human ABR tests. The method terminates level averaging of ABR recordings upon detection of time-locked waveform through cross-correlation analysis. The threshold level was then indicated by a dramatic increase in the sweep numbers required to produce \"qualified\" level averaging. A good match was obtained between the algorithm outcome and the human readouts. Moreover, the method varies the level averaging based on the cross-correlation, thereby adapting to the signal-to-noise ratio of single sweep recordings. These features empower a robust and fully automated ABR test.","funder":"NA","published":"10.1016\/j.isci.2021.103285","server":"medRxiv"}]}